Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Winter Games
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

FDA, rna and Flu Shot

Digest more
Top News
Overview
Investor's Business Daily on MSN · 7d
Moderna plunges after FDA rejects its messenger-RNA-based flu shot
The FDA rejected Moderna's experimental flu vaccine Tuesday in a move that proved to be a blow to recently hot Moderna stock.

Continue reading

 · 6d · on MSN
FDA defends its decision to not review Moderna’s mRNA flu shot
 · 10h
Moderna Says the FDA Will Consider Its New Flu Shot After Resolving a Public Dispute
 · 8h
Moderna says FDA to review its flu vaccine after reversing course
The U.S. Food and Drug Administration has reversed an earlier decision and said it will review drugmaker Moderna's application for approval of a seasonal flu vaccine, the company said in a statement W...

Continue reading

 · 1h
Opinion: An anti-science FDA is a threat to our health and prosperity
 · 8h
US FDA reverses course, will review Moderna's revised flu vaccine application
Scientific American
7d

FDA won’t consider a new mRNA vaccine for flu despite the technology’s life-saving promise

America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots
Kalkine Media
7d

Moderna (NASDAQ:MRNA) Aligned With Nasdaq Index Biotech Presence

Moderna advances messenger RNA platform technologies Therapeutics pipeline spans vaccines and disease targets nasdaq index inclusion reflects biotech scale Moderna, Inc. (NASDAQ:MRNA) operates within the biotechnology sector and remains a recognized component of the broader nasdaq index,
BURSA
6d

FDA refuses to review Moderna's mRNA flu vaccine

The American pharmaceutical company Moderna announced that the United States Food and Drug Administration (FDA) has refused to review the application for authorization for its flu vaccine based on mes
Yahoo
1mon

Bayer sues COVID vaccine makers over mRNA technology

Jan 6 (Reuters) - Bayer's Monsanto sued COVID-19 vaccine makers Pfizer, BioNTech and Moderna in Delaware federal court on Tuesday for allegedly misusing its messenger RNA technology ‌in manufacturing their vaccines, a Bayer spokesperson confirmed.
The Economist
6mon

RFK Jr’s attack on mRNA technology endangers the world

DURING THE covid-19 pandemic new vaccines were rolled out with unprecedented speed. The fastest to arrive were jabs built from molecules of messenger RNA (mRNA) designed to teach the body how to fight off the disease-causing virus. By late 2021, mRNA ...
  • Privacy
  • Terms